Skip to main content
Clinical Trials/ACTRN12614001219673
ACTRN12614001219673
Completed
未知

Multiparametric MRI as a Predictor of Tumour Response in Patients with Anal Canal Cancer Managed with Chemoradiotherapy

Dr Michael Jones0 sites20 target enrollmentNovember 19, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Anal Cancer
Sponsor
Dr Michael Jones
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dr Michael Jones

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient capable of providing informed consent
  • 2\.Patient deemed suitable for protocol treatment as
  • assessed by Radiation and Medical Oncologists
  • 3\.Histological diagnosis of invasive primary squamous
  • cell carcinoma of the anal canal
  • 4\.TNM Stage: T2\-4, N0\-3 based on the
  • following diagnostic workup
  • a.History \& physical examination
  • b.Digital Rectal Exam (DRE) stating primary size and
  • distance from anal verge

Exclusion Criteria

  • 1\.ECOG performance status \>2
  • 2\.Significant comorbidities that would interfere with
  • the completion of treatment
  • 3\.Renal insufficiency (Creatinine \> 150\)
  • 4\.Prior radiotherapy to the pelvis that would overlap in
  • the treatment fields
  • 5\.Prior surgery for cancer of the anus that removed all
  • macroscopic cancer
  • 6\.Prior systemic chemotherapy for anal cancer
  • 7\.Evidence of distant metastases (M1\) if this precludes

Outcomes

Primary Outcomes

Not specified

Similar Trials